Negative regulatory pathways in T cell quiescence and T cell response
T 细胞静止和 T 细胞反应中的负调控途径
基本信息
- 批准号:8549950
- 负责人:
- 金额:$ 24.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-24 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntigensAscaridilAutoimmunityBiological AssayBiological ModelsCell CycleCell Cycle ProgressionCell LineageCell MaintenanceCell SizeCell divisionCellsCellular ImmunityChIP-seqClinicalCommunicable DiseasesDataDevelopmentFutureGene Expression ProfilingGene TargetingGenetic TranscriptionGoalsGrowthHomeostasisImmune responseImmunityKineticsLifeMaintenanceMature T-LymphocyteMemoryMetabolismMolecularMusPathway interactionsPlayProcessProliferatingProtein IsoformsProteinsReceptor SignalingRegulationRegulator GenesRegulatory PathwayResearchRestRetinoblastoma ProteinRoleSignal PathwayStagingSupporting CellT cell differentiationT cell responseT memory cellT-Cell ActivationT-Cell DevelopmentT-Cell ProliferationT-Cell ReceptorT-LymphocyteTestingTherapeuticTranscriptional RegulationTransgenic Miceantigen challengebasecell growthgenome-wideinsightlong term memoryloss of functionmembermouse modelnovelpublic health relevanceresponsetranscription factorvaccine development
项目摘要
DESCRIPTION (provided by applicant): At the transcriptional level, little is known about the pathways that are associated with the active maintenance of T cell quiescence. We recently showed that cell-intrinsic signaling pathways are required to maintain mature T cells in a quiescent state; if these pathways are disrupted, resting T cells become aberrantly activated even in lympho-replete hosts in the absence of antigen challenge (Nat Immunol 2011). Our long-term goals are to identify such regulatory genes and pathways that actively restrain T cel activation, and to define their roles in T cell quiescence, T cell homeostasis, and in primary and memory T cell responses. In the immediate future, specifically, we are asking how the pathways associated with T cell quiescence impact the rate and extent of T cell activation, thereby affecting the kinetics and magnitude of the response and effector and memory T cell differentiation. We will also address a long-recognized but poorly understood process that is fundamental to the maintenance of memory T cells: is enforcing memory T cell quiescence an essential mechanism for long-term memory survival? The studies will provide fundamental information and new mechanistic insights to guide therapeutic manipulation of T cell quiescence versus activation in a broad range of clinical settings including autoimmunity, infectious diseases, and vaccine development. Recently we have identified Foxp1 as an essential transcription regulator for maintaining the quiescence of naive T cells during homeostasis. In this proposal, we will determine the role of Foxp1 proteins in the antigen-induced T cell response and elucidate the mechanisms whereby Foxp1 enforces quiescence. The two specific aims are: 1) Determine the regulation of Foxp1 on T cel activation and memory. We have generated several Foxp1 isoform-specific conditional transgenic mice as well as a Foxp1 inducible deletion mouse model. We will utilize these novel gain- and loss-of-function mouse lines to elucidate the role of Foxp1 and its isoforms in T cel activation and memory. 2) Elucidate the molecular mechanisms by which Foxp1 enforces T cell quiescence. Recently we have established a genome-wide Foxp1 ChIP-sequencing assay and identified a number of novel Foxp1-candidate target genes. We will combine both candidate and unbiased genome-wide approaches to elucidate how the Foxp1 pathway negatively regulates cell growth/metabolism and cell cycle progression, thereby enforcing T cell quiescence. Based on the unique mouse lines and model systems that we have established and the unique insights of Foxp1 targets, our study is highly significant as it has the potential to reveal several novel and important molecular
mechanisms underlying the transcriptional network of Foxp1 in regulating T cell quiescence, activation and memory.
描述(由申请人提供):在转录水平上,人们对与 T 细胞静止的主动维持相关的途径知之甚少。我们最近表明,细胞内在信号通路是维持成熟 T 细胞处于静止状态所必需的;如果这些途径被破坏,即使在没有抗原攻击的情况下,即使在淋巴细胞充足的宿主中,静息 T 细胞也会异常激活 (Nat Immunol 2011)。我们的长期目标是识别主动抑制 T 细胞激活的调节基因和通路,并确定它们在 T 细胞静止、T 细胞稳态以及初级和记忆 T 细胞反应中的作用。具体而言,在不久的将来,我们要问的是与 T 细胞静止相关的通路如何影响 T 细胞激活的速率和程度,从而影响反应以及效应和记忆 T 细胞分化的动力学和幅度。我们还将讨论一个长期被认可但知之甚少的过程,该过程对于维持记忆 T 细胞至关重要:强制记忆 T 细胞静止是长期记忆存活的重要机制吗?这些研究将提供基本信息和新的机制见解,以指导在包括自身免疫、传染病和疫苗开发在内的广泛临床环境中 T 细胞静止与激活的治疗操作。 最近,我们发现 Foxp1 是一种重要的转录调节因子,可在稳态过程中维持初始 T 细胞的静止。在本提案中,我们将确定 Foxp1 蛋白在抗原诱导的 T 细胞反应中的作用,并阐明 Foxp1 强制静止的机制。两个具体目标是: 1) 确定 Foxp1 对 T 细胞激活和记忆的调节。我们已经生成了几种 Foxp1 异构体特异性条件转基因小鼠以及 Foxp1 诱导缺失小鼠模型。我们将利用这些新的功能获得和丧失的小鼠系来阐明 Foxp1 及其亚型在 T 细胞激活和记忆中的作用。 2) 阐明Foxp1强制T细胞静止的分子机制。最近,我们建立了全基因组 Foxp1 ChIP 测序分析,并鉴定了许多新的 Foxp1 候选靶基因。我们将结合候选和无偏全基因组方法来阐明 Foxp1 通路如何负向调节细胞生长/代谢和细胞周期进程,从而强制 T 细胞静止。 基于我们建立的独特的小鼠品系和模型系统以及对Foxp1靶点的独特见解,我们的研究具有非常重要的意义,因为它有可能揭示一些新颖且重要的分子
Foxp1 转录网络调节 T 细胞静止、激活和记忆的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hui Hu其他文献
Hui Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hui Hu', 18)}}的其他基金
Transcriptional Regulation of CD4+ T Cell Differentiation and Diversified Memory
CD4 T 细胞分化和多样化记忆的转录调控
- 批准号:
10714458 - 财政年份:2023
- 资助金额:
$ 24.25万 - 项目类别:
Transcriptional Regulation of CD4+ T Cell Differentiation and Diversified Memory
CD4 T 细胞分化和多样化记忆的转录调控
- 批准号:
10741301 - 财政年份:2022
- 资助金额:
$ 24.25万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10645046 - 财政年份:2021
- 资助金额:
$ 24.25万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10523580 - 财政年份:2021
- 资助金额:
$ 24.25万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10214088 - 财政年份:2021
- 资助金额:
$ 24.25万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10414064 - 财政年份:2021
- 资助金额:
$ 24.25万 - 项目类别:
Hypertensive Disorders of Pregnancy and Early Risk of Maternal CVD: Influence of the External Exposome
妊娠期高血压疾病和孕产妇心血管疾病的早期风险:外部暴露的影响
- 批准号:
10771766 - 财政年份:2021
- 资助金额:
$ 24.25万 - 项目类别:
Regulation of Tfh cell differentiation and humoral immunity
Tfh细胞分化和体液免疫的调节
- 批准号:
10165471 - 财政年份:2017
- 资助金额:
$ 24.25万 - 项目类别:
Transcriptional regulation of T cell quiescience and activation
T 细胞静止和激活的转录调控
- 批准号:
8872018 - 财政年份:2012
- 资助金额:
$ 24.25万 - 项目类别:
相似国自然基金
E3泛素连接酶MDM2对乙肝表面抗原组装和分泌的影响及机制研究
- 批准号:82300690
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
甲型流感病毒H1N1变异对抗原性和感染性的影响机制研究
- 批准号:82372225
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
幽门螺杆菌O-抗原连接酶WaaL通过调控IV型分泌系统的组装影响其致病性的机制研究
- 批准号:82300649
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ATP6V0C通过调控溶酶体功能影响泡沫细胞抗原提呈能力致麻风菌免疫逃逸的机制研究
- 批准号:82273545
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
新型H5亚型禽流感病毒变异对抗原性影响及其分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 24.25万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 24.25万 - 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
- 批准号:
10495114 - 财政年份:2023
- 资助金额:
$ 24.25万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 24.25万 - 项目类别:
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
- 批准号:
10784250 - 财政年份:2023
- 资助金额:
$ 24.25万 - 项目类别: